SCHEMBL1421131

SCHEMBL1421131

Cc1ccc(S(=O)(=O)N[C@@H](CCCCN)C(=O)C(Cl)C=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 4/20 0.53
▸ MMP9 P14780 2/20 0.53
▸ PLAU P00749 5/20 0.44
▸ HPN P05981 5/20 0.44
▸ TDP1 Q9NUW8 1/20 0.41
▸ ITGB3 P05106 1/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ SLC1A3 P43003 1/20 0.41
▸ SLC1A2 P43004 1/20 0.41
▸ SLC1A1 P43005 1/20 0.41
▸ CA2 P00918 3/20 0.40
▸ CA12 O43570 2/20 0.40
▸ CA9 Q16790 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ CA1 P00915 2/20 0.39
▸ MMP13 P45452 2/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ MMP1 P03956 1/20 0.38
▸ MMP8 P22894 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL284482 1.00 MMP2 (0.53) MMP2MMP9PLAUHPNTDP1
SCHEMBL1115907 0.87 MMP2 (0.56) MMP2MMP9PLAUHPNTDP1
SCHEMBL284484 0.87 MMP2 (0.56) MMP2MMP9PLAUHPNTDP1
SCHEMBL6571626 0.84 MMP9 (0.65) MMP2MMP9PLAUHPNTDP1
SCHEMBL796114 0.84 MMP9 (0.65) MMP2MMP9PLAUHPNTDP1
SCHEMBL5470148 0.83 MMP2 (0.57) MMP2MMP9PLAUHPNTDP1
SCHEMBL5470145 0.83 MMP2 (0.57) MMP2MMP9PLAUHPNTDP1
Hydrochloric Acid SCHEMBL14059215 0.83 MMP9 (0.64) MMP2MMP9PLAUHPNTDP1
SCHEMBL28509074 0.83 MMP2 (0.60) MMP2MMP9PLAUHPNTDP1
SCHEMBL8965842 0.82 MMP9 (0.65) MMP2MMP9PLAUHPNTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110086005-A1 MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTION ONCOLYTICS BIOTECH INC. (CA) 2011-04-14 — — US claimed
EP-1708677-A2 COSMETIC COMPOSITION CONTAINING A PROTEIN AND AN ENZYME INHIBITOR E-L Management Corp. (US) 2006-10-11 — — EP claimed
WO-2005067691-A2 COSMETIC COMPOSITION CONTAINING A PROTEIN AND AN ENZYME INHIBITOR E-L MANAGEMENT CORPORATION (US) 2005-07-28 — — WO claimed
US-20050147572-A1 Cosmetic composition containing a protein and an enzyme inhibitor E-L MANAGEMENT CORP. 2005-07-07 — — US claimed
EP-0230670-B1 NOVEL HOST E. COLI AND USE THEREOF SUNTORY LIMITED (JP) 1991-07-03 — — EP claimed
WO-2024151802-A2 METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ITCH PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-07-18 — — WO disclosed
US-20240158513-A1 FC Variants and Methods for Their Production GENENTECH, INC. (US) 2024-05-16 — — US disclosed
US-10689447-B2 Fc variants and methods for their production GENENTECH, INC. (US) 2020-06-23 — — US disclosed
EP-2670776-B1 Fc VARIANTS AND METHODS FOR THEIR PRODUCTION HOFFMANN LA ROCHE (CH) 2018-11-21 — — EP disclosed
WO-2018055235-A1 ISOXAZOLE-AMIDES FOR TREATING CARDIAC DISEASES UNIVERSITY OF HELSINKI (FI) 2018-03-29 — — WO disclosed
US-9841423-B2 Methods for diagnosing and treating Helicobacter pylori infection NATIONAL TSING HUA UNIVERSITY (TW) 2017-12-12 — — US disclosed
US-20170082621-A1 METHODS FOR DIAGNOSING AND TREATING HELICOBACTER PYLORI INFECTION NATIONAL TSING HUA UNIVERSITY (TW) 2017-03-23 — — US disclosed
EP-1708677-A2 COSMETIC COMPOSITION CONTAINING A PROTEIN AND AN ENZYME INHIBITOR E-L Management Corp. (US) 2006-10-11 — — EP disclosed
WO-2005067691-A2 COSMETIC COMPOSITION CONTAINING A PROTEIN AND AN ENZYME INHIBITOR E-L MANAGEMENT CORPORATION (US) 2005-07-28 — — WO disclosed
US-20050147572-A1 Cosmetic composition containing a protein and an enzyme inhibitor E-L MANAGEMENT CORP. 2005-07-07 — — US disclosed
US-6331610-B1 TREATING VIRAL DISEASES IN HUMAN CELLS AND TISSUES; ADMINISTER VIRICIDES, MONITOR CELLS FOR VIRAL EXPRESSION METATRON, INC. 2001-12-18 — — US disclosed
WO-2000052034-A2 INHIBITORS OF SERINE PROTEASE ACTIVITY, METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTIONS THE TRUSTEES OF UNIVERSITY TECHNOLOGY CORPORATION (US) 2000-09-08 — — WO disclosed
EP-0360840-A1 CYTOLYTIC FACTOR BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1990-04-04 — — EP disclosed
WO-1988007868-A1 CYTOLYTIC FACTOR BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1988-10-20 — — WO disclosed
WO-1988000236-A1 METHODS AND MATERIALS FOR VANADIUM IMMUNOMODULATION TOMPKINS WAYNE A F (US) 1988-01-14 — — WO disclosed
Send feedback